Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 4
2020 5
2021 1
2022 2
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
CD5 and CD6 as immunoregulatory biomarkers in non-small cell lung cancer.
Moreno-Manuel A, Jantus-Lewintre E, Simões I, Aranda F, Calabuig-Fariñas S, Carreras E, Zúñiga S, Saenger Y, Rosell R, Camps C, Lozano F, Sirera R. Moreno-Manuel A, et al. Transl Lung Cancer Res. 2020 Aug;9(4):1074-1083. doi: 10.21037/tlcr-19-445. Transl Lung Cancer Res. 2020. PMID: 32953486 Free PMC article.
Validation of Melanoma Immune Profile (MIP), a Prognostic Immune Gene Prediction Score for Stage II-III Melanoma.
Gartrell RD, Marks DK, Rizk EM, Bogardus M, Gérard CL, Barker LW, Fu Y, Esancy CL, Li G, Ji J, Rui S, Ernstoff MS, Taback B, Pabla S, Chang R, Lee SJ, Krolewski JJ, Morrison C, Horst BA, Saenger YM. Gartrell RD, et al. Clin Cancer Res. 2019 Apr 15;25(8):2494-2502. doi: 10.1158/1078-0432.CCR-18-2847. Epub 2019 Jan 15. Clin Cancer Res. 2019. PMID: 30647081 Free PMC article.
Combination immunotherapy including OncoVEXmGMCSF creates a favorable tumor immune micro-environment in transgenic BRAF murine melanoma.
Gartrell RD, Blake Z, Rizk EM, Perez-Lorenzo R, Weisberg SP, Simoes I, Esancy C, Fu Y, Davari DR, Barker L, Finkel G, Mondal M, Minns HE, Wang SW, Fullerton BT, Lozano F, Chiuzan C, Horst B, Saenger YM. Gartrell RD, et al. Cancer Immunol Immunother. 2022 Aug;71(8):1837-1849. doi: 10.1007/s00262-021-03088-y. Epub 2022 Jan 9. Cancer Immunol Immunother. 2022. PMID: 34999916 Free PMC article.
Correction to: The Role of Oncolytic Viruses in the Treatment of Melanoma.
Bayan CY, Lopez AT, Gartrell RD, Komatsubara KM, Bogardus M, Rao N, Chen C, Hart TD, Enzler T, Rizk EM, Pradhan JS, Marks DK, Geskin LJ, Saenger YM. Bayan CY, et al. Curr Oncol Rep. 2018 Nov 13;20(12):100. doi: 10.1007/s11912-018-0749-z. Curr Oncol Rep. 2018. PMID: 30426304
Deep Learning Based on Standard H&E Images of Primary Melanoma Tumors Identifies Patients at Risk for Visceral Recurrence and Death.
Kulkarni PM, Robinson EJ, Sarin Pradhan J, Gartrell-Corrado RD, Rohr BR, Trager MH, Geskin LJ, Kluger HM, Wong PF, Acs B, Rizk EM, Yang C, Mondal M, Moore MR, Osman I, Phelps R, Horst BA, Chen ZS, Ferringer T, Rimm DL, Wang J, Saenger YM. Kulkarni PM, et al. Clin Cancer Res. 2020 Mar 1;26(5):1126-1134. doi: 10.1158/1078-0432.CCR-19-1495. Epub 2019 Oct 21. Clin Cancer Res. 2020. PMID: 31636101 Free PMC article.
11 results